Amlodipine Besylate Tablet
Product Images NDC 71610-956

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0956 45)

Label (71610 0956 45)
Label for Amlodipine Besylate USP 5 mg oral tablets. The label indicates a bottle containing 45 tablets. It includes storage instructions, manufacturer information (CorePharma, LLC, Middlesex, NJ), and repackager information (Aphena Pharma, Cookeville, TN). The NDC number displayed is 71610-956-45.*
FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemstruc (Chemstruc)

Chemstruc (Chemstruc)
Chemical structure diagram of Amlodipine Besylate showing its molecular arrangement and components, including a chlorophenyl group and various functional groups consistent with the chemical formula C6H6O3S.*
FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A line graph depicting event rates over a 24-month period comparing Amlodipine and placebo groups. The x-axis shows time in months, and the y-axis shows event rate. The graph includes a box noting a p-value of 0.003, a hazard ratio of 0.691, and a 95% confidence interval of 0.54 to 0.88. The number of subjects at risk decreases over time, displayed below the x-axis.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A hazard ratio forest plot comparing Amlodipine to placebo across various patient subgroups including age, gender, baseline sitting systolic blood pressure, vessel disease, vessel stenosis, and PCI-stent status. The horizontal axis represents hazard ratio with 95% confidence intervals, indicating favor towards Amlodipine on the left and placebo on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.